Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Autor: Bauer, Franz, Berbec, Nicoleta, Besses Raebel, Carlos, Borbenyi, Zita, Bumbea, Horia, Buxhofer-Ausch, Veronika, Calbecka, Malgorzata, Cayssials-Caylus, Emilie, Cazzola, Mario, Cerna, Olga, Cucuianu, Andrei, Dima, Delia Monica, Forjan, Ernst, Gheorghita, Emanuil, Greil, Richard, Hatalova, Antonia, Hrubisko, Mikulas, Jakucs, Janos, Kaplan, Polina, Klymenko, Sergiy, Koschmieder, Steffen, Lazaroiu, Mihaela, Lysa, Tamila, Masliak, Zvenyslava, Masszi, Tamas, Mihaylov, Georgi, Myasnikov, Alexander, Platzbecker, Uwe, Puyade, Mathieu, Rey, Jerome, Roy, Lydia, Schwarz, Jiri, Skotnicki, Aleksander, Sokolova, Irina, Soroka-Wojtaszko, Maria, Starzak-Gwozdz, Jolanta, Stoeva, Vera, Torregrosa-Diaz, Jose Miguel, Vallova, Anna, Volodicheva, Elena, Warzocha, Krzysztof, Willenbacher, Ella, Wolf, Dominik, Gisslinger, Heinz ^*, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Rossiev, Viktor, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiri, Yablokova, Vera, Krejcy, Kurt, Grohmann-Izay, Barbara, Hasselbalch, Hans C, Kralovics, Robert, Kiladjian, Jean-Jacques

Publikováno v: In The Lancet Haematology March 2020 7(3):e196-e208

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b

Autor: Kiladjian, Jean-Jacques, Klade, Christoph, Georgiev, Pencho, Krochmalczyk, Dorota, Gercheva-Kyuchukova, Liana, Egyed, Miklos, Dulicek, Petr, Illes, Arpad, Pylypenko, Halyna, Sivcheva, Lylia, Mayer, Jiří, Yablokova, Vera, Krejcy, Kurt, Empson, Victoria, Hasselbalch, Hans C., Kralovics, Robert, Gisslinger, Heinz

Publikováno v: PROUD-PV Study Grp 2022, ' Long-term outcomes of polycythemia vera patients treated with ropeginterferon Alfa-2b ', Leukemia, vol. 36, no. 5, pp. 1408-1411 . https://doi.org/10.1038/s41375-022-01528-x

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::950caeea9e7b240210474f46a7445ae5
https://ruj.uj.edu.pl/xmlui/handle/item/290500

Germline genetic factors influence the outcome of interferon-α therapy in polycythemia vera

Autor: Jäger, Roland, Gisslinger, Heinz, Fuchs, Elisabeth, Bogner, Edith, Milosevic Feenstra, Jelena D., Weinzierl, Jakob, Schischlik, Fiorella, Gisslinger, Bettina, Schalling, Martin, Zörer, Michael, Krejcy, Kurt, Klade, Christoph, Kralovics, Robert ^*

Publikováno v: In Blood 21 January 2021 137(3):387-391